|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.49 USD | +9.15% |
|
+9.80% | -12.16% |
| Apr. 01 | Wells Fargo Cuts Affimed Price Target to $25 From $30, Maintains Overweight Rating | MT |
| Apr. 01 | HC Wainwright Adjusts Affimed's Price Target to $10 From $50, Maintains Buy Rating | MT |
Affimed N.V. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EUR 8.28 million compared to EUR 41.35 million a year ago. Net loss was EUR 105.94 million compared to EUR 86 million a year ago.
Basic loss per share from continuing operations was EUR 7.09 compared to EUR 6.04 a year ago. Diluted loss per share from continuing operations was EUR 7.09 compared to EUR 6.04 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -12.16% | 76.59M | |
| -2.63% | 103B | |
| +1.62% | 95.28B | |
| +1.46% | 22.15B | |
| -16.67% | 21.02B | |
| -8.58% | 18.15B | |
| -38.74% | 16.73B | |
| -13.21% | 16.05B | |
| +5.41% | 13.68B | |
| +33.57% | 12.17B |
AFFIMED N.V. 
